Antibody–Drug Conjugates for Cancer Therapy

Mostrar otras versiones (1)

Antibody–drug conjugates (ADCs) take advantage of the specificity of a monoclonal antibody to deliver a linked cytotoxic agent directly into a tumour cell. The development of these compounds provides exciting opportunities for improvements in patient care. Here, we review the key issues impacting on...

Descripción completa

Detalles Bibliográficos
Autores principales: Parslow, Adam C., Parakh, Sagun, Lee, Fook-Thean, Gan, Hui K., Scott, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344263/
https://www.ncbi.nlm.nih.gov/pubmed/28536381
http://dx.doi.org/10.3390/biomedicines4030014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344263/
https://www.ncbi.nlm.nih.gov/pubmed/28536381
http://dx.doi.org/10.3390/biomedicines4030014

Ejemplares similares